Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
EBITDA grew 46.9% YoY to Rs. 210.3 crore with EBITDA margin at 18.2%, grew 401 bps YoY and the reported PAT at Rs. 90 crore
Scored 85/100, 2.3x the industry average in Social and 73/100, 1.8x the industry average in Governance
This certification will open new markets for the Kwality Pharma
Genext Genomics can now offer comprehensive solutions that support the growth of India’s biotech ecosystem
Revenue at Rs 3,623 crore, EBITDA at Rs 718 crore
Union Government will provide a health cover of Rs. 5 lakh to any elderly person above 70 years of age
The share subscription agreements are being executed at a pre-money equity value of US$ 1.65 billion
The company will now seek final approval from NCLT, Mumbai Bench, and upon its receipt, OneSource will proceed to seek listing approvals from the BSE and NSE
Subscribe To Our Newsletter & Stay Updated
